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Efficient stop codon recognition and peptidyl-tRNA
hydrolysis are essential in order to terminate transla-
tional elongation andmaintainprotein sequencefidel-
ity. Eukaryotic translational termination is mediated
by a release factor complex that includes eukaryotic
release factor 1 (eRF1) and eRF3. The N terminus
of eRF1 contains highly conserved sequence motifs
that couple stop codon recognition at the ribosomal
A site to peptidyl-tRNA hydrolysis. We reveal that Ju-
monji domain-containing 4 (Jmjd4), a 2-oxoglutarate-
and Fe(II)-dependent oxygenase, catalyzes carbon
4 (C4) lysyl hydroxylation of eRF1. This posttransla-
tional modification takes place at an invariant lysine
within the eRF1NIKSmotif and is required for optimal
translational termination efficiency. These findings
further highlight the role of 2-oxoglutarate/Fe(II)
oxygenases in fundamental cellular processes and
provide additional evidence that ensuring fidelity of
protein translation is a major role of hydroxylation.
INTRODUCTION
Hydroxylation was historically considered a rare posttransla-
tional modification largely restricted to proteins involved in extra-
cellular matrix formation (Walsh, 2005). The discovery of protein
hydroxylases that regulate hypoxia signaling (Kaelin and Rat-
cliffe, 2008), together with widespread ankyrin repeat hy-
droxylation (Coleman and Ratcliffe, 2009), suggested that this
posttranslational modification may in fact be common but rela-
tively poorly characterized.
Many protein hydroxylases belong to the family of 2-oxogluta-
rate (2OG)- and Fe(II)-dependent oxygenases (2OG oxygenases)Molethat oxidizes diverse substrates, including lipid, nucleic acid, and
small molecules (Kaelin and Ratcliffe, 2008; Klose et al., 2006;
Loenarz and Schofield, 2011). Since these enzymes also require
molecular oxygen for activity, they have the potential to act as
oxygen sensors. A family of prolyl hydroxylases (PHD1–PHD3)
that targets hypoxia-inducible transcription factor (HIF-a) for
proteasomal degradation is inactivated by hypoxia (Kaelin and
Ratcliffe, 2008; Loenarz and Schofield, 2008). In addition to their
role in hypoxia signaling, 2OG oxygenases are involved in a
variety of other fundamental cellular processes, such as chro-
matin remodeling. A subfamily of 2OG oxygenases with a com-
mon JmjC catalytic domain catalyzes histone demethylation
via a hydroxylation reaction (Klose et al., 2006; Loenarz and
Schofield, 2008).
The role of 2OG oxygenases in regulating HIF-a transcrip-
tional activity and histone demethylation is consistent with the
emerging role for these enzymes in regulating gene expression.
Jmjd6 is aJmjC2OGoxygenase that catalyzes carbon5 (C5) lysyl
hydroxylation of arginine/serine-rich (RS) domain splicing factors
and histones (Unoki et al., 2013; Webby et al., 2009). Recent re-
ports suggest that 2OG oxygenases may also regulate gene
expression at the level of protein synthesis. AlkbH8 hydroxylates
5-methoxycarbonylmethyluridine at the wobble position of tRNA
anticodons (Fu et al., 2010; van den Born et al., 2011). Similarly,
TYW5 catalyzes the hydroxylation of a hypermodified guanosine
in the phenylalanine tRNA anticodon (Noma et al., 2010). Further-
more, two related JmjC 2OG oxygenases, MINA53 and NO66,
hydroxylate ribosomal proteins Rpl27a and Rpl8, respectively,
at specific histidyl residues proximal to the peptidyl transferase
center (Ge et al., 2012). Whether other 2OG oxygenases also
regulate protein synthesis is unknown but would be of consider-
able interest considering the importance of protein translation in
gene expression regulation and disease.
In this study, we identify an uncharacterized JmjC 2OG oxy-
genase, Jmjd4, as a regulator of translational termination—a
fundamental cellular process required for decoding stop codons
and maintaining protein sequence fidelity. We show that Jmjd4cular Cell 53, 645–654, February 20, 2014 ª2014 Elsevier Inc. 645
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stop codon recognition domain of an essential release factor
termed eRF1. Jmjd4 regulates translational termination via hy-
droxylation of K63 at the C4 position of the side chain. C4 lysyl
hydroxylation represents a posttranslational modification not
previously widely described in animals.
RESULTS
Jmjd4 Interacts with Translational Termination Factor
eRF1
Ribosomal hydroxylases, Jmjd6, and the asparaginyl hydroxy-
lase FIH (factor inhibiting HIF) belong to a subfamily of 2OG oxy-
genases that share a JmjC catalytic domain related to that in
2OG-dependent histone demethylases (Ge et al., 2012; Klose
et al., 2006) (Figure S1A available online). We hypothesized
that uncharacterized enzymes of this family would include regu-
lators of gene expression. Jmjd4 is a highly conserved putative
2OG oxygenase that contains residues required for enzymatic
activity and shares 34% sequence identity with that of the lysyl
hydroxylase Jmjd6 (Figures 1A, S1A, and S1B). To investigate
the function of Jmjd4, we screened for substrates by identifying
proteins that only interact with the wild-type active enzyme.
Affinity purification of FLAG-Jmjd4 and mass spectrometry
(MS) did not identify known Jmjd6 substrates (Unoki et al.,
2013; Webby et al., 2009), RS domain proteins, or histones
(data not shown). The most abundant activity-dependent
Jmjd4 interactors were eRF1 and eRF3a (Figure S1C), which
are nonredundant proteins required for stop codon recognition
and translational termination (Kisselev and Buckingham, 2000;
Nakamura and Ito, 2011). Immunoblot analysis confirmed that
the eRF1/eRF3a complex specifically interacts with wild-type
FLAG-Jmjd4 (Figure 1B), but not a Jmjd4 mutant predicted to
be inactive due to defective Fe(II) binding (H189A; see Figure 1A)
or FIH. The stoichiometry of binding indicated that eRF1, rather
than eRF3a, likely interacts directly with FLAG-Jmjd4 (Figures
1B and S1C). Consistent with their interaction, FLAG-Jmjd4
and endogenous eRF1 are cytoplasmically localized in human
embryonic kidney 293T (HEK293T) cells (Figure 1C). Further-
more, endogenous eRF1 specifically interacts with endogenous
Jmjd4, but not FIH or Jmjd6 (Figure 1D).
Jmjd4 Is a 2-Oxoglutarate/Fe(II)-Dependent Oxygenase
that Hydroxylates eRF1 at K63
To test whether Jmjd4 hydroxylates eRF1 and/or eRF3a, overex-
pression vectors were cotransfected into HEK293T cells: anti-V5
purification of the V5-eRF1/HA-eRF3a complex, followed by
proteolysis and MS analysis, identified a single hydroxylation
site in eRF1 at K63 (Figure S1D), with 20% hydroxylation in con-
trol cells and >95% in cells overexpressing FLAG-Jmjd4 (Fig-
ure 1E). These data indicate that exogenous FLAG-Jmjd4 can
promote lysyl hydroxylation of overexpressed eRF1 in cells. To
test whether Jmjd4 catalyzes eRF1 hydroxylation directly, we
incubated recombinant Jmjd4 and eRF1 in the presence of co-
factors in vitro; eRF1 K63 hydroxylation was efficiently catalyzed
by wild-type Jmjd4, but not the inactive H189A mutant (Fig-
ure 2A). In contrast to wild-type eRF1, K63A and K63R mutants
were not efficiently hydroxylated (Figure 2A), thus confirming the646 Molecular Cell 53, 645–654, February 20, 2014 ª2014 Elsevier Inspecificity of Jmjd4 and further assigning the position of eRF1
hydroxylation.
Previously characterized 2OG oxygenases depend on key nu-
trients andmetabolites for activity, including oxygen, Fe(II), 2OG,
and in some cases ascorbate (Loenarz and Schofield, 2008). To
explore the enzymatic activity of Jmjd4 in more detail, we per-
formed in vitro hydroxylation assays in the presence or absence
of known cofactors and inhibitors. Under these conditions eRF1
K63 hydroxylation was significantly impaired by a 2OG compet-
itive inhibitor (NOG, N-Oxalylglycine) or the absence of either
Fe(II) or 2OG (Figure 2B). These data confirm that Jmjd4 is a
bona fide 2OG- and Fe(II)-dependent oxygenase.
Jmjd4 Is a C4 Lysyl Hydroxylase
Known lysyl hydroxylases (Jmjd6 and collagen hydroxylases)
catalyze hydroxylation at C5 of the amino acid side chain (Webby
et al., 2009). In order to investigate the target specificity of Jmjd4,
we first attempted to hydroxylate a 24-mer eRF1 peptide for
amino acid analyses. However, in contrast to full-length recom-
binant eRF1 (Figures 2A and 2B), quantitative MS provided little
evidence for hydroxylation (<5%), even when using stoichio-
metric Jmjd4 and saturating levels of cofactors. We postulated
that this was due to inappropriate conformational presentation
of the linear peptide at the Jmjd4 active site. Crystallographic
analyses reveal that K63 is at the apex of a tight turn between
two antiparallel a helices (Figure S2A) (Song et al., 2000). In an
effort to obtain a mimic of the structurally observed conforma-
tion, we analyzed the eRF1 crystal structure and proposed that
appropriately cyclized eRF1 peptide fragments may be more
efficient substrates (Figure S2B). We found that a thioether-
linked dimer (containing eRF1 residues 57–70 twice) supported
relatively efficient hydroxylation at both K63 sites by Jmjd4,
whereas Jmjd6 did not catalyze hydroxylation, demonstrating
different specificities of the two hydroxylases (Figure S2C). Com-
parison of chemically synthesized C3 and C4 hydroxylysine
standards (for NMR see Figures S2D and S2E, respectively) to
commercially available C5 hydroxylysine and the K63-hydroxyl-
ated eRF1 cyclic peptide indicated that in contrast to known
2OG-dependent lysyl hydroxylases, Jmjd4 is in fact a C4 lysyl
hydroxylase (Figures 2C, 2D, and S2F). These findings indicate
that Jmjd4 is a 2OG oxygenase that catalyzes a posttranslational
modification not widely described in animals previously.
Endogenous eRF1 K63 Hydroxylation Is Abundant,
Ubiquitous, and Dependent on Jmjd4 Enzyme Activity
Next, we aimed to characterize the hydroxylation of endogenous
eRF1. Immunopurification of endogenous eRF1 from HEK293T
cells followed by tandem mass spectrometry (MS/MS)
sequencing of tryptic (Figure 3A) or Arg-C (Figure S3A) protease
fragments confirmed that endogenous eRF1 is hydroxylated at
K63. Liquid chromatography (LC)-MS quantitation of the same
tryptic peptide showed that hydroxylation was essentially com-
plete, within the limits of detection (>95%; Figure 3B). Similar re-
sults were obtained with endogenous eRF1 purified from HeLa,
A549, and U2OS cells (Figures 3B and 3C). To determine
whether endogenous eRF1 K63 hydroxylation requires Jmjd4,
we suppressed the expression of the endogenous enzyme by
siRNA. Knockdown of Jmjd4 expression substantially inhibitedc.
Figure 1. Jmjd4 Interacts with the eRF1/eRF3a Translational Termination Complex in an Activity-Dependent Manner
(A) Protein sequences of human JmjC domains were aligned and shaded using Jalview. The Jmjd6 secondary structure, as defined by crystallographic analysis
(Mantri et al., 2010), is indicated with a helices (cylinders) and b strands (arrows). The conserved double-stranded b helix core is in cyan (arrows). Triangles
indicate residues binding Fe(II) (red) and 2OG (yellow). Mutation of the first Fe(II)-binding residue (His189 in Jmjd4) is predicted to inhibit activity.
(B) Anti-FLAG immunoprecipitates of cell extracts from the indicated HEK293T cell lines were immunoblotted for endogenous eRF1 and eRF3a. Input (5%) = cell
extract prior to immunoprecipitation (IP). eRF1 levels were quantified by densitometry analysis using NIH ImageJ.
(C) HEK293T cell lines were immunostained for eRF1 (green) and FLAG-Jmjd4 (red). Nuclei were visualized with DAPI (blue).
(D) Endogenous eRF1 and Jmjd4 interact. eRF1 was immunoprecipitated from HEK293T extracts prior to immunoblot for the indicated proteins.
(E) Overexpressed Jmjd4 promotes hydroxylation of overexpressed eRF1 at K63. Left: Coomassie gel showing 5% input following anti-V5 purification of the
V5-eRF1/HA-eRF3a complex from HEK293T cells overexpressing empty vector or FLAG-Jmjd4 (immunoblot bottom panel). The remainder of the sample (95%)
was digested with Arg-C in-solution prior to LC-MS analyses. The chromatograms indicate the elution time and relative abundance of extracted ion masses
corresponding to unhydroxylated (blue) and K63-hydroxylated (red) eRF148–65 ([M+H]
3+; K63-H: m/z 646.68; K63-OH: m/z 652.00) in the absence (middle) and
presence (right) of FLAG-Jmjd4. See also Figure S1.
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Figure 2. Jmjd4 Catalyzes 2OG- and Fe(II)-Dependent C4 Lysyl Hydroxylation of eRF1
(A) K63 mutation prevents Jmjd4-dependent hydroxylation of eRF1. Left: Coomassie gel of partially purified recombinant eRF1 and mutants. Right: LC-MS
extracted ion chromatograms (EICs) show wild-type and mutant eRF1 reacted with either wild-type (top row) or mutant H189A (bottom row) Jmjd4. ([M+H]2+;
K63-H: m/z 698.842; K63-OH: m/z 706.840; K63R-H: m/z 712.846; K63R-OH: m/z 720.843; K63A-H: m/z 791.880; K63A-OH: m/z 799.878).
(B) Jmjd4 is a 2OG/Fe(II)-dependent oxygenase. In vitro assays were performed in the presence or absence of the indicated cofactors and inhibitors. 2OG
oxygenases are competitively inhibited by NOG, a nonhydrolysable form of 2OG. Data represent mean ± SEM. Statistical significance was evaluated by ANOVA
followed by Dunett’s post hoc test, comparing all treatments to the reaction complemented with all cofactors (n.s., not significant; **p < 0.01).
(C) Jmjd4 is a C4 lysyl hydroxylase. Bottom: a cyclic thioether-linked dimer of a 15-mer peptide containing eRF1 residues 57–70 was untreated (buffer, black) or
Jmjd4 hydroxylated (red) prior to hydrolysis and LC-MS. Top: chromatography peaks observed in biological samples were identified with C3, C4, and/or C5
hydroxylysine standards. Note that two peaks are observed because each standard is amixture of stereoisomers. See Figure S2 for NMR of standards and further
validation of the C4 assignment.
(D) Schematic of C4 lysyl hydroxylation catalyzed by Jmjd4. See also Figure S2.
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and 3D), suggesting that other lysyl hydroxylases are unlikely
to contribute to its hydroxylation. To test whether these effects
were due to reduced Jmjd4 activity, we transfected Jmjd4
siRNA into cells that ectopically express Jmjd4 siRNA-resistant
mRNAs, which were either wild-type or inactive (Figures 3C
and 3D). Expression of hemagglutinin (HA)-Jmjd4 successfully
restored eRF1 hydroxylation, whereas HA-Jmjd4 H189A did
not. Taken together, these data indicate that the abundant and
ubiquitous hydroxylation of endogenous eRF1 in tissue culture
cell lines is dependent on Jmjd4 catalytic activity. To determine
whether eRF1 K63 hydroxylation is a physiologically relevant
modification, we next purified eRF1 from a variety of mammalian
tissues. Importantly, LC-MS analyses of eRF1 purified from
several mouse tissues and rabbit reticulocyte lysate indicated
that eRF1 hydroxylation is abundant (>90%) and conserved
(Figure 3E).
Endogenous eRF1 K63 Hydroxylation Is Dependent on
2-Oxoglutarate and Oxygen
Consistent with the requirement of eRF1 K63 hydroxylation for
Jmjd4 activity, treatment of HeLa, U2OS, and Hep3B cells with
a cell permeable form of the 2OG competitor NOG (dimethy-
loxalylglycine; DMOG) also reduced the hydroxylation of newly
synthesized eRF1 (Figure S3B and data not shown). 2OG
oxygenases also depend on molecular oxygen to create a
hydroxyl group in the prime substrate. To test the sensitivity of
eRF1 hydroxylation to oxygen availability, we incubated HeLa,
U2OS, and Hep3B cells in normoxia (21% O2), hypoxia (1%
and 0.1%O2), and anoxia (0%O2). MS analyses of eRF1 synthe-
sized under these conditions confirmed that K63 hydroxylation
was reduced by profound hypoxia (Figure S3C and data not
shown). However, Jmjd4 retains substantial activity even under
severe hypoxia (%1% O2), similar to some related 2OG oxy-
genases (Ge et al., 2012; Tian et al., 2011), suggesting that it
is unlikely to act as an oxygen sensor analogous to the HIF
hydroxylases (Kaelin and Ratcliffe, 2008).
Jmjd4 Activity Is Required for Translational Termination
Termination of eukaryotic protein translation is mediated by
eRF1, the guanosine triphosphatase (GTPase) eRF3, and the
ATPase ABCE1 (Kisselev et al., 2003; Shoemaker and Green,
2011). eRF1 consists of three functional domains: domain 1 de-
codes stop codons, domain 2 facilitates peptidyl-tRNA hydroly-
sis, and domain 3 recruits eRF3 (Figure 4A) (Nakamura and Ito,
2011). Consistent with a role in stop codon recognition, a cryoe-
lectron microscopy (cryo-EM) structure of the ribosomal preter-
mination complex places domain 1 deep within the decoding
center of the 40S subunit (Taylor et al., 2012). Functional studies
have implicated highly conserved motifs in domain 1 (e.g., GTX,
YXCXXXF, and NIKS) (Figure 4A) in stop codon recognition and
its coupling to peptidyl-tRNA hydrolysis (Bertram et al., 2000;
Conard et al., 2012; Fan-Minogue et al., 2008; Frolova et al.,
2002; Song et al., 2000). Crosslinking experiments suggest that
under some conditions the lysine within the NIKS motif contacts
the uridine nucleotide in the first position of a stop codon (Cha-
vatte et al., 2002). Although the precise molecular function of
the NIKS motif is under debate, it is known to play an importantMolerole in translational termination (Bertram et al., 2000; Conard
et al., 2012; Frolova et al., 2002; Kisselev et al., 2003; Nakamura
and Ito, 2011; Song et al., 2000). Critically, the lysine within this
motif (K63; Figure 4A) is the residue hydroxylated by Jmjd4
to >90% in the steady state. Therefore, we hypothesized that
K63 hydroxylationmay promote eRF1 function and that its inhibi-
tion could cause stop codon readthrough. To test this, we used
established stop codon readthrough reporters consisting of tan-
dem in-frame Renilla and firefly luciferase cDNAs separated by
each stop codon (Renilla:stop:firefly) (Figure 4B) (Grentzmann
et al., 1998). Stop codon readthrough is indicated by an increase
in firefly relative to Renilla luciferase activities. Importantly,
knockdown of Jmjd4 or eRF1 in HeLa, U2OS, or Hep3B cells
induced readthrough of all three stop codons embedded within
a ‘‘leaky’’ termination sequence (Figures 4C, S4A, and S4B).
These effects were apparently specific to termination and trans-
lation, as they were not observed with sequences lacking a stop
codon (Renilla:CAG:firefly) (Figures 4C, S4A, and S4B) and were
not associated with aberrant transcript splicing or changes in
abundance of firefly relative to Renilla luciferase mRNAs (Figures
S4C–S4E) (Holcik et al., 2005; Lemp et al., 2012). Furthermore,
these effects were specific to Jmjd4 (at least among closely
related hydroxylases), since siRNA knockdown of FIH, MINA53,
and Jmjd6 did not induce stop codon readthrough (Figure S4F).
To further explore the specificity and generality of these
results, we tested an independent stop codon reporter (Fig-
ure S4G) in an additional cell type: Jmjd4 or eRF1 siRNA in
A549 cells also increased readthrough of a stop codon within a
leaky termination sequence when using a b-galactosidase:stop:
firefly reporter (Figures S4H and S4I, respectively). Importantly,
similar results were also obtained using the same reporter with
a stop codon embedded in a ‘‘strong’’ termination sequence
(Figure S4J). Taken together, the results presented here suggest
that Jmjd4 may have a widespread role in translational termina-
tion, perhaps consistent with ubiquitous and abundant eRF1 K63
hydroxylation (Figure 3).
To determine whether the role of Jmjd4 in translational termi-
nation depends on its hydroxylase activity, we repeated knock-
downs in cells expressing siRNA-resistant wild-type or inactive
Jmjd4 mRNAs. Jmjd4 siRNA induced stop codon readthrough
in inactive HA-Jmjd4 cells (Renilla:stop:firefly reporter), whereas
cells expressing wild-type HA-Jmjd4 retained normal transla-
tional termination (Figure 4D) consistent with restored eRF1
hydroxylation (Figure 3C). As expected, eRF1 siRNA was still
sufficient for stop codon readthrough in cells expressing
siRNA-resistant Jmjd4 mRNA, but not in those expressing
siRNA-resistant eRF1 (Figure 4D). Similar results demonstrating
a requirement for Jmjd4 activity were obtained with the b-galac-
tosidase:stop:firefly reporter using either the leaky or strong
termination sequence (Figures S4K–S4M). Together, these
data indicate that Jmjd4 catalysis promotes translational termi-
nation efficiency.
K63 Hydroxylation Promotes the Translational
Termination Efficiency of eRF1 In Vitro
Next, we sought to determine whether the role of Jmjd4 activity
in translational termination in cells is a direct consequence
of eRF1 K63 hydroxylation. To this end, we used a fullycular Cell 53, 645–654, February 20, 2014 ª2014 Elsevier Inc. 649
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measured by the release of translated peptides from stalled
pretermination complexes (Alkalaeva et al., 2006). Consistent
with previous reports (Alkalaeva et al., 2006; Kryuchkova
et al., 2013), unhydroxylated recombinant eRF1 exhibited sub-
stantial catalytic efficiency in this assay (1  2 Kcat/KM 3 104
[M1s1]). Importantly, however, partial K63 hydroxylation
(60%; data not shown) further increased eRF1 termination
efficiency at all three stop codons (Figures 4E, 4F, and S4N).
In contrast, an eRF1 K63R mutant failed to show any increase
in activity following incubation with Jmjd4, thereby assigning
the effect of Jmjd4 on translation termination to hydroxylation
of K63.
DISCUSSION
The work presented here describes the regulatory modification
of a highly conserved region of eRF1 known to play an important
role in translational termination (Bertram et al., 2000; Conard
et al., 2012; Fan-Minogue et al., 2008; Frolova et al., 2002;
Song et al., 2000). We have shown that hydroxylation of the
eRF1NIKSmotif promotes polypeptide release frompretermina-
tion ribosomal complexes in vitro and that reduced Jmjd4 activ-
ity causes stop codon readthrough in vivo (Figure 4). Previously
known posttranslational modifications of eRF1 are limited to
phosphorylation of domain 3 (Kallmeyer et al., 2006) and N5-
glutamine methylation of a GGQ motif within domain 2 required
for peptidyl-tRNA hydrolysis (Graille et al., 2012). In contrast to
the consistent effects of Jmjd4-dependent NIKS hydroxylation
(Figure 4), the effect of these modifications on eukaryotic trans-
lational termination is unclear.
A general role for K63 hydroxylation during a fundamental
step in translational termination may be consistent with the
abundance and ubiquity of eRF1 hydroxylation (Figure 3), and
the requirement for Jmjd4 activity observed across multiple
experimental models, cell types and stop codon contexts (Fig-
ures 4 and S4). Hydroxylation can modulate protein function
via intra- or intermolecular hydrogen-bonds or electronic effects
(Coleman et al., 2007; Hon et al., 2002; Loenarz and Schofield,
2011). Recent studies suggest that the loop containing the
NIKS motif and the helical extension surrounding it have some
inherent plasticity (Polshakov et al., 2012). An interaction be-
tween hydroxylated-K63 and a neighboring eRF1 residue could
modulate this flexibility and optimize the conformation of thisFigure 3. Endogenous eRF1 K63 Hydroxylation Is Abundant, Ubiquitou
(A) HEK293T eRF1 was trypsinized prior to MS/MS. Spectra show a +16 Da mas
(unhydroxylated) and lower (hydroxylated) panels. In contrast, the masses of det
indicating K63 hydroxylation. This was confirmed with Arg-C proteolysis (Figure
(B) LC-MS analyses of trypsinized eRF1 indicate abundant K63 hydroxylation inm
K63 hydroxylated (red) eRF151–63 ([M+H]
2+; K63-H: m/z 698.842; K63-OH: m/z 7
(C) EICs demonstrate that eRF1 hydroxylation is dependent on Jmjd4 activity ([
relative to (B) due to SILAC (stable isotope labeling by/with amino acids in cell
HA-Jmjd4 (middle), or siRNA-resistant HA-Jmjd4 H189A mRNAs (right) were tr
labeling and LC-MS quantitation of hydroxylation in newly synthesized eRF1. N
Jmjd4 siRNA, total eRF1 is 50% hydroxylated due to persisting eRF1 synthesi
(D) Cell extracts from (C) were immunoblotted for the indicated proteins. eRF1 le
(E) Similar analyses in rodent tissues indicate that eRF1 hydroxylation is physiolog
mouse tissues were diluted or homogenized in lysis buffer prior to eRF1 purifica
Moledomain during stop codon recognition and/or subsequent steps
of termination. Alternatively, K63 hydroxylation could mediate an
interaction with the stop codon Uridine (Chavatte et al., 2002),
ribosome or other molecules involved in the termination process.
The exact molecular mechanism by which eRF1 K63 hydroxyl-
ation regulates translational termination is unclear, and will be
the subject of future investigation.
The completeness of K63 hydroxylation may argue against
a switch-like function in normal tissues. Rather, the fact that
Jmjd4 requires key nutrients for activity raises the possibility
that nutrient stress, pathological conditions or pharmacological
intervention could promote stop codon readthrough via inhibi-
tion of eRF1 hydroxylation. Regulated stop codon readthrough
may provide a means of controlling eukaryotic gene expression
(Steneberg et al., 1998; Yamaguchi et al., 2012). Furthermore,
pharmacological readthrough of premature termination codons
is attracting interest as a therapeutic approach for treating dis-
eases caused by nonsense mutations (Bidou et al., 2012). The
possibility that targeting Jmjd4 could promote the action of these
agents is of interest.
Finally, our study provides insights into the expanding biology
of 2OG oxygenases. Previous examples of lysyl-hydroxylation
are restricted to the C5 position. Our results demonstrate that
2OG oxygenases can also hydroxylate at C4 (Figure 2). This
raises the possibility that other forms of lysyl-hydroxylation
also exist, possibly catalyzed by related but as yet unassigned
Jmjd proteins. Together with recently identified hydroxylations
of ribosomal proteins (Ge et al., 2012) and tRNA anticodons
(Fu et al., 2010; Noma et al., 2010; van den Born et al., 2011)
the work also suggests that protein translation, and particularly
‘decoding’, may be a major target of 2OG oxygenases.EXPERIMENTAL PROCEDURES
Plasmid construction and culture, transfection, and treatment of cells are
described in the Supplemental Experimental Procedures. Immunoblotting
was performed as previously described (Ge et al., 2012). Recombinant human
eRF1 was purified as described (Frolova et al., 2002). Human recombinant
Jmjd4 was purified from E. coli lysates using Ni-NTA resin (QIAGEN) following
standard procedures. For reporter assays, siRNA-treated cells were trans-
fected with reporter vectors for 48 hr before lysis in passive lysis buffer (Prom-
ega). Samples were freeze thawed before measuring luciferase activities using
the Dual-Luciferase System (Promega). For the b-galactosidase:stop:firefly
vector, luciferase was assayed using luciferin (Promega) and b-galactosidase
with the FluorAce Kit (Bio-Rad). All assays were performed on a Safire2s, and Dependent on Jmjd4 Activity
s shift in all detected y ion fragments (y2–y12) (blue) when comparing the upper
ected b ion fragments (b2–b12) (red) are consistent with their predicted values,
S3A).
ultiple cell types. EICs show relative abundance of unhydroxylated (blue) versus
06.840).
M+H]2+; K63-H: m/z 701.852; K63-OH: m/z 709.850). The masses are +3 Da
culture) with K+6. HeLa cells expressing empty vector (left), siRNA-resistant
ansfected with control (top row) or Jmjd4 siRNA (bottom row) prior to SILAC
ote that although hydroxylation of newly synthesized eRF1 is <15% following
zed prior to siRNA (data not shown).
vels were quantified by densitometry analysis.
ically relevant and conserved. Rabbit reticulocyte lysate (RRL) and the indicated
tion, trypsinolysis, and MS analyses. See also Figure S3.
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Figure 4. eRF1 K63 Hydroxylation Promotes Translational Termination Efficiency
(A) Top: K63 is located at the apex of an a-helical extension within eRF1 domain 1 (Chimera and Protein Data Bank ID 1DT9) (Song et al., 2000). Bottom: alignment
of the eRF1 NIKS region, indicating complete conservation of K63 across diverse species (Jalview).
(B) A bicistronic reporter for measuring stop codon readthrough (Grentzmann et al., 1998) with luciferase cDNAs separated by a stop or sense codon (CAG) within
a leaky termination sequence from tobacco mosaic virus.
(C) Jmjd4 knockdown promotes stop codon readthrough. Left: HeLa cells were transfected with the reporters in (B) prior to siRNA (si) and dual luciferase assay.
Note that K63 hydroxylation is 50% under similar knockdown conditions (see Figure 3 legend). Data represent mean ± SEM. Statistical significance was
evaluated by ANOVA followed byDunett’s post hoc test comparing Jmjd4 and eRF1 knockdown samples to control (**p < 0.01). Right: immunoblot of cell extracts
(n.s., nonspecific).
(D) Jmjd4 activity is required for efficient translational termination. Top: stop codon readthrough assays were performed as in (C) using HeLa cell lines expressing
empty vector, siRes-HA-Jmjd4, siRes-HA-Jmjd4 H189A, or siRes-HA-eRF1 mRNAs. Bottom: immunoblot of cell extracts. Data represent mean ± SEM.
Comparisons across cell lines were made by ANOVA followed by Bonferroni post hoc test (**p < 0.01).
(E) K63 hydroxylation increases the catalytic efficiency of eRF1 in vitro. Unhydroxylated (post-Jmjd4-H189A treatment; blue) or hydroxylated (post-Jmjd4
treatment; red; 60% hydroxylation) wild-type (left) or K63R (right) eRF1 were added to pretermination ribosomal complexes before quantifying released
(legend continued on next page)
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Hydroxylation Promotes Translational TerminationMicroplate Reader (Tecan). Experimental procedures used for mouse tissue
analysis passed ethical review by theMedical Sciences divisional Local Ethical
Review panel (Oxford University) and were performed under UK Home Office
regulations (Animal [Scientific Procedures] Act 1986). Details of the remaining
methods are provided in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.molcel.2013.12.028.
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